Brief: Circio To Test Combination Of TG01 Vaccination With Daratumumab And Nivolumab
Nov 16 (Reuters) - Circio Holding ASA CRNA.OL :
* CIRCIO JOINS COLLABORATION TO TEST COMBINATION OF TG01
VACCINATION WITH DARATUMUMAB AND NIVOLUMAB IN IMMUNOTHERAPY
RESISTANT PATIENTS WITH MUTANT RAS CANCERS
Source text for Eikon: ID:nObitmSsHa
Further company coverage: CRNA.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Circio Holding ASA
See all newsBrief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration
Brief: Circio And Aavigen To Collaborate On In Heart Gene Therapy
Brief: Circio Commences Exercise Period For Warrants
Brief: Circio Holding Files New Circvec Patent Application
Brief: Circio, Traffikgene Enter Research Collaboration